(function(){var loadHandler=window['sl_{B169E353-1691-4AFC-B51D-F07AF60FC333}'];loadHandler&&loadHandler(16, '<div id="spr0_587871d4"><div id="spr1_587871d4" class="kern slide"><img id="img5_587871d4" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_587871d4" class="kern slide"><img id="img0_587871d4" src="data/img23.png" width="721.48" height="83.382" alt="" style="left:-1.48px;"/><div id="svg1_587871d4" style="left:-1.48px;top:83.736px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_587871d4" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_587871d4" src="data/img8.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_587871d4" style="left:657.715px;top:499.855px;"><img id="img2_587871d4" src="data/img9.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_587871d4" style="left:-1.48px;top:20.166px;"><div style="width:0px;"><span id="txt0_587871d4" data-width="364.183594" style="left:171px;top:5.272px;">PCSK9 Inhibitors are Safe</span></div></div><div id="spr5_587871d4" style="left:6.496px;top:503.199px;"><div style="width:0px;"><span id="txt1_587871d4" class="nokern relpos" data-width="6.156738" style="left:7.2px;top:4.096px;">a.</span><span id="txt2_587871d4" class="nokern relpos" data-width="180.953613" style="left:19.043px;top:4.096px;">Sebatine MS, et al. N Engl J Med. 2017;376:1713-1722</span></div><div style="width:0px;"><span id="txt3_587871d4" class="nokern relpos" data-width="6.156738" style="left:7.2px;top:14.896px;">b.</span><span id="txt4_587871d4" class="nokern relpos" data-width="182.583984" style="left:19.043px;top:14.896px;">Schwartz GG, et al. N Engl J Med. 2018:379:2097-2107</span></div></div><div id="spr6_587871d4" style="left:0.83px;top:117.486px;"><img id="img3_587871d4" src="data/img24.png" width="363" height="321" alt="" style="left:0.096px;top:0.17px;"/></div><div id="spr7_587871d4" style="left:373.475px;top:117.486px;"><img id="img4_587871d4" src="data/img25.png" width="346" height="371" alt="" style="left:-0.153px;top:-0.141px;"/></div><div id="spr8_587871d4" style="left:16.506px;top:90.183px;"><div style="width:0px;"><span id="txt5_587871d4" class="relpos" data-width="163.195313" style="left:93.971px;top:4.436px;">FOURIER: Evolocumab</span><span id="txt6_587871d4" class="relpos" data-width="12.023438" style="left:93.966px;top:4.632px;">(a)</span></div></div><div id="spr9_587871d4" style="left:364.727px;top:89.564px;"><div style="width:0px;"><span id="txt7_587871d4" class="relpos" data-width="237.858398" style="left:56.678px;top:4.436px;">ODYSSEY Outcomes: Alirocumab</span><span id="txt8_587871d4" class="relpos" data-width="12.562500" style="left:56.673px;top:4.632px;">(b)</span></div></div></div></div>');})();